Subscribe
Intermittent dosing of vemurafenib extended the lives of lab mice with drug-resistant melanoma tumors, according to results of an international study.
UV nail lamps don't cause skin cancer
Imiquimod battles melanoma in situ and more
When to perform sentinel lymph node biopsy depends on various factors
High-tech imaging modalities identify perineural spread of head and neck malignancies
Joseph Gorelick, MSN, FNP-C
Brad P. Glick, DO, MPH, FAAD
Hilary Baldwin; Neal Bhatia, MD
Tina Bhutani, MD
June 17-19, 2026
Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD
Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc
Andrew Alexis, MD, MPH; Leon Kircik, MD
Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD
Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD